Status:

UNKNOWN

HBV Vaccine in Anti-core Positive Donors After LT

Lead Sponsor:

Hospital Clinic of Barcelona

Collaborating Sponsors:

University of Padova

Hospital Vall d'Hebron

Conditions:

Hepatitis B Reactivation

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

Anti-HBc positive liver donors frequently have occult HBV infection, and several studies in HBsAg-negative subjects have shown that there is often the detection in the liver of covalently closed circu...

Detailed Description

HYPOTHESIS The hypothesis of the study is that active immunization may be successful in up to 20% of patients who received an anti-HBc+ liver during transplantation after the first vaccination schedul...

Eligibility Criteria

Inclusion

  • Age between 18 and 75 years- old.
  • HBsAg-negative pre-transplantation
  • Liver transplant recipients; more than 2 years from the date of LT
  • Transplantation of a graft from an HBV anti-core positive donor
  • Patients should be under nucleoside analogue therapy with Lamivudine, Tenofovir or Entecavir
  • Stable immunosuppressive therapy during the last 6 months
  • Baseline anti-HBs levels \<100 IU/L (HBV vaccination while on the waiting list is allowed and will be recorded)
  • Willingness to participate in the study and written inform consent

Exclusion

  • • HBsAg positive at any time post-transplantation
  • HBV-DNA positive at any time post-transplantation
  • Any HBIG dose during the last 12 months
  • HBV vaccination after liver transplantation
  • Spontaneous or vaccine-induced post-transplant anti-HBs titers ≥ 100 UI/L
  • Any rejection episode during the last 12 months
  • Positive HCV-RNA at time of vaccination
  • HCV therapy with direct acting antivirals within the previous 12 months
  • HIV coinfection
  • Advanced fibrosis after LT (liver stiffness measurement ≥ 9.5 kPa)
  • Pregnancy

Key Trial Info

Start Date :

September 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2023

Estimated Enrollment :

114 Patients enrolled

Trial Details

Trial ID

NCT04442841

Start Date

September 1 2020

End Date

January 1 2023

Last Update

July 31 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Liver Unit, Hospital Clinic

Barcelona, Spain, 08036